Ubiquitin-like (UBL) -ubiquitin-associated (UBA) proteins, including Dsk2 and Rad23, act as delivery factors that target polyubiquitinated substrates to the proteasome. We report here that the Dsk2 UBL domain is ubiquitinated in yeast cells and that Dsk2 ubiquitination of the UBL domain is involved in Dsk2 stability, depending on the Dsk2 UBA domain. Also, Dsk2 lacking ubiquitin chains impaired ubiquitin-dependent protein degradation and decreased the interaction of Dsk2 with polyubiquitinated proteins in cells. Moreover, Dsk2 ubiquitination affected ability to restore the temperature-sensitive growth defect of dsk2 . These results indicate that ubiquitination in the UBL domain of Dsk2 has in vivo functions in the ubiquitin-proteasome pathway in yeast.
3
proteins have a regulatory role in the recognition and delivery of polyubiquitinated proteins.
In yeast, three UBL-UBA proteins; Rad23, Dsk2, and Ddi1, are known to be such delivery proteins. In this process, "mobile" UBL-UBA proteins interact with the proteasome together with polyubiquitinated proteins, and they are selectively degraded. UBL-UBA proteins that interact with the proteasome, however, can escape degradation. It has been demonstrated that the Rad23 UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from proteasomal degradation and the UBA2 domain deletion mutant is unstable [15] . As predicted by Walters [16] , intra-molecular interactions between the UBL and UBA domains seem to contribute to the stability of Rad23/hHR23A.
Budding yeast Dsk2 is a UBL-UBA protein that helps deliver polyubiquitinated proteins to the proteasome [17] [18] [19] . To better understand the molecular mechanisms of UBL-UBA proteins in the ubiquitin-proteasome pathway, we investigated the role of Dsk2 ubiquitination using lysine mutants of the Dsk2 UBL domain. Dsk2 is quite stable in yeast [20] , but we show here that Dsk2 is ubiquitinated in yeast in the UBL domain, and that ubiquitin chains of the UBL domain mediate the degradation of Dsk2 defective in the UBA domain. Dsk2 ubiquitination of UBL domains also affected ubiquitin-dependent degradation in yeast. We discuss physiological relevance of the ubiquitination of the Dsk2 UBL domain in Dsk2 stability as well as in the ubiquitin-proteasome pathway.
Materials and methods

Strains, plasmids, and media
Saccharomyces cerevisiae YPH499 (MATa ade2-101 leu2- trp1-63 ura3-52 lys2-801 his3-200), used as the wild-type strain, was previously described [17] . Mutant strains (dsk2 , rpn1-821, and pre2-75, dsk2  , dsk2 rad23 ), media, and growth conditions were described previously [17, 21] . Plasmids carrying the glutathione S-transferase (GST)-tagged version pEG-KG-DSK2, were described previously [17] . Multi-copy plasmids pGAL1-YEplac195 harboring DSK2 or pGAL1-YEplac112 harboring His 6 -T7-ubiquitin were used for the ubiquitination assay [17] . A single-copy plasmid pRS316 harboring DSK2 and its endogenous promoter was used for complementation of dsk2 . The growth of a dsk2 rad23 strain transformed by this plasmid was tested on plates of minimal medium containing 2% glucose minus uracil [17] . For complementation of uracil auxotrophy, a single-copy plasmid, pRS314, harboring URA3-fused DSK2 was transformed into YPH499 and these transformed strains were incubated on plates of minimal medium containing 2% glucose minus uracil and tryptophan at 30 o C for 3 days.
Construction of Dsk2 mutants
DSK2 deletion mutants and Dsk2 UBA domain mutants were described previously [17, 21] . The arginine-substituted mutants of the UBL domain were constructed by site-directed polymerase chain reaction (PCR) methods using pEG-KG-DSK2 as the template. 
Binding assay and degradation of Dsk2 in vivo
For the binding assay, His 6 -T7-ubiquitin and Dsk2 were co-expressed in yeast, and cell extracts in lysis buffer containing 1 mM EGTA instead of EDTA were incubated with Talon 5 metal-affinity resin (CLONTECH) [17] . Talon resin or glutathione-Sepharose beads were used to pull down His 6 -T7-ubiquitin, and the bound material was immunoblotted with anti-Dsk2 or anti-T7 antibodies. For detection of ubiquitinated Dsk2, Dsk2 was co-expressed with His 6 -T7-ubiquitin in yeast, and the Talon resin pull-down was immunoblotted with anti-Dsk2
antibody. For the degradation assay, GST-DSK2 in pEG-KG or DSK2 in pGAL1-YEplac195 was transformed into yeast. Dsk2 was overexpressed for 4 h by the addition of 2% galactose.
Cell extracts were collected at 30 min intervals after the induction was shut off by adding dextrose to the medium, followed by immunoblotting with anti-Dsk2, anti-Cdc28, anti-Ddi1
(UBL-UBA protein), and anti-mAb414 (nuclear NPC) antibodies. For degradation of N-end rule substrate Leu--gal [6] , Dsk2 or Dsk2-KR in YCplac22 was co-expressed with Ub-Leu--gal in dsk2 strain under the control of the GAL1 promoter. After incubation at 30 o C for 4 h, galactose-induction was shut off and cell samples were taken at 20 min intervals followed by immunoblotting with anti--gal antibody.
Results
The UBL domain of Dsk2 is required for ubiquitin-dependent degradation of UBA domain-defective Dsk2.
Dsk2 is considered to be a stable protein [20] , but Dsk2/Rad23 mutants that are defective in the UBA domain become unstable [15] . To investigate the role of UBL and UBA domains of Dsk2 in its own stability, we constructed a series of Dsk2-truncated mutants ( was induced into proteasome mutant strains pre2 and rpn1 followed by immunoblotting with 6 anti-Dsk2 antibody (Fig. 1B) . LL368AA was stabilized in pre2 (lane 4) and rpn1 (lane 6), whereas LL368AA was barely detectable in the wild-type strain (lane 2). In comparison, wild-type Dsk2 was stable (lanes 1, 3, 5). To confirm this result, LL368AA was expressed in a dsk2 background (Fig 1C) . Again, LL368AA expressed in dsk2 was rapidly degraded, whereas LL368AA expressed in dsk2 rpn1 was stable (right panel).
Second, we used a genetic method to confirm the dependence of Dsk2 instability on the ubiquitin-proteasome pathway. A series of Ura3-fused Dsk2 constructs and their UBA mutant (Ura3-1-335) were made ( Fig. 1D ). The stability of these Ura3-fused constructs in yeast cells was evaluated by immunoblotting. Ura3-fused Dsk2 was stable, but Ura3-1-335 was unstable in YPH499 (summarized in Fig. 1D , left panel). These constructs were then transformed into a parental strain YPH499, and we tested whether Ura3-fused Dsk2 complemented the uracil auxotrophy of YPH499 based on its growth on plated of minimal medium without uracil, the complementation of which is an indication for the stabilization of Ura3-Dsk2 protein in cells.
As expected, YPH499 expressing Ura3-Dsk2 grew and YPH499 expressing Ura3-1-335 failed to grow (middle panel), because Ura3-1-335 was unstable. The proteasome mutant pre2 strain expressing Ura3-1-335, however, did grow on plates of minimal medium without uracil (middle panel). The same result was obtained for rpn1 (right panel). These genetic results (summarized in the left panel) indicate that Dsk2 UBA mutant 1-335 became stable in the proteasome mutant strain. Therefore, the Dsk2 UBA mutants were degraded in the ubiquitin-proteasome pathway depending on the UBL domain.
The UBL domain of Dsk2 is ubiquitinated in yeast cells.
In the course of our experiments on yeast Dsk2, we detected endogenous Dsk2 with a laddered banding pattern on the immunoblot. As this pattern was reminiscent of ubiquitinated proteins, we tested the ubiquitination status of Dsk2. A pull-down experiment in which His 6 -T7-ubiquitin was precipitated with Talon resin, and the bound materials were immunoblotted with anti-Dsk2
antibody. Ubiquitin chains of Dsk2 were confirmed ( Fig. 2A, lane 8) .
We next determined the region of Dsk2 that is ubiquitinated. All eight lysine residues of Dsk2 lie within the UBL domain (K8, K13, K28, K33, K49, K52, K72, K76) and these residues in the UBL domain are highly conserved from yeast to humans (Fig. 2B) . We constructed an arginine-substituted mutant of the Dsk2 UBL domain (Dsk2-KR) in which the eight lysine residues were replaced by arginine (Fig. 2B, bottom) . To test the ubiquitination status of Dsk2-KR in cells, Dsk2-KR was expressed in dsk2 as in Fig 2A, followed by a pull-down with
Talon resin of the cell extracts and immunoblotting with anti-Dsk2 antibody (Fig. 2C ).
Compared with wild-type Dsk2 (lane 11), Dsk2-KR was not ubiquitinated (lanes 12, 13). Thus, the lysine residues in the UBL domain of Dsk2 are ubiquitinated in yeast.
Ubiquitin chains of the Dsk2 UBL domain mediate Dsk2 own stability.
We investigated whether ubiquitin chains are required for the instability of UBA-defective Dsk2. UBL/UBA double mutants [21] were constructed (Fig. 3A) to test for their degradation (Fig. 3B) as before. All of the double mutants; KR/GF343AA (lanes 10-12), KR/GS359AA
(lanes [16] [17] [18] , and KR/LL368AA (lanes 22-24), were stable in YPH499 (Fig. 3B) . Degradation of Dsk2 via UBA domain, therefore, requires ubiquitin chains of Dsk2 UBL domain. Consistent with this stability, all of these mutants were not ubiquitinated in the cells (Fig. 3C, lanes 8-11) .
These results show clearly that Dsk2-KR recovers the instability of the Dsk2 UBA mutants. We therefore concluded that UBA-defective Dsk2 was degraded in the ubiquitin-proteasome pathway mediated by ubiquitin chains of the UBL domain. Wild-type Dsk2 was ubiquitinated, but still stable, suggesting that endogenous Dsk2 can escape from degradation even when it is fully ubiquitinated (see Discussion).
Dsk2 ubiquitination affects in vivo ubiquitin-dependent protein degradation.
UBL-UBA proteins such as Dsk2 function in the delivery of ubiquitinated substrates to the 8 proteasome. We investigated whether ubiquitin chains of the UBL domain affect Dsk2 function in yeast cells.
First, the effect of ubiquitin chains in the Dsk2 UBL domain on protein degradation in vivo was examined by using the N-end rule substrate Leu--gal. DSK2 disruption impairs degradation of Leu--gal in the cells [17] . A single copy of wild-type Dsk2 or Dsk2-KR was expressed in dsk2 (Fig. 4A) . Defective degradation of Leu--gal in dsk2 restored by the expression of wild-type Dsk2, but was not by Dsk2-KR.
Second, the effect of ubiquitin chains on the interaction of Dsk2 with polyubiquitinated proteins in cells was examined. GST-Dsk2-KR was coexpressed with His 6 -T7-ubiquitin in yeast, and the GST pull-down was immunoblotted with anti-T7 and anti-Dsk2 antibodies ( Next, the complementation of DSK2 disruption by Dsk2-KR was tested using the growth defect of dsk2 rad23 . A strain with deletions of both DSK2 and RAD23 is temperature-sensitive for growth although a disruption of DSK2 alone is viable [20] . A single copy of Dsk2-KR was expressed in dsk2 rad23 (Fig. 4C, left) . Dsk2-KR had decreased ability to complement the temperature-sensitive growth of dsk2 rad23 , whereas wild-type Dsk2 was able to fully complement growth.
Growth arrest of yeast and the accumulation of large amount of polyubiquitinated proteins in cells are caused by overexpression of wild-type Dsk2 in yeast [7, 17] , which seem to be involved in Dsk2 function in the ubiquitin-proteasome pathway. When the effect of ubiquitin chains on the Dsk2-mediated growth arrest was examined, overexpressed Dsk2-KR failed to inhibit the growth as expected (Fig. 4C, 
Ubiquitin chains of the Dsk2 UBL domain are a signal for Dsk2 degradation in yeast cells.
The UBL domain and the UBA domain interact with the proteasome and the polyubiquitinated proteins, respectively. UBA domain-defective Dsk2 protein, which fails to bind polyubiquitin chains of the degradation substrates, can bind to the proteasome via its UBL domain. As a result, such dysfunctional Dsk2 would occupy the proteasome receptor. In this condition, such dysfunctional Dsk2 must be degraded (eliminated) rapidly in cells. Our results show that ubiquitin chains of the Dsk2 UBL domain serve as a signal for Dsk2 degradation (Fig. 3) . We suggest that the UBL domain-mediated Dsk2 degradation take part in eliminating dysfunctional
Dsk2 from the receptor site of the proteasome.
The UBL domain has eight lysine residues and the UBL domain sequence of Dsk2 has high similarity to ubiquitin (Fig. 2B) . When the ubiquitination status of a series of lysine mutants was tested in more detail, the K28/K33 mutant was ubiquitinated but the K28R/K33R mutant was less with different molecular weight shifts (see Supplement data). It is thus likely that ubiquitin chains of Dsk2 are conjugated mainly through K28/K33 of the UBL domain. In the absence of lysines in K28/K33, however, other K sites can be used to form different chains. Based on our preliminary experiment on K28R and/or K33R mutants, Dsk2 ubiquitination seems to depend mainly on K28 rather than K33 (data not shown). We suspect that K28 of the UBL domain (equivalent to ubiquitin K29) may be a probable candidate for a major chain linkage in the UBL domain, but further analysis is required on the molecular details.
Dsk2 UBA domain may bind alternatively ubiquitin chains of the UBL domain and of polyubiquitinated substrates.
The Dsk2 UBA domain in vitro binds both K48-and K29-linked chains [22] , and the UBA domain interacts with the UBL domain intramolecularly [23] . The Dsk2 UBA in cells binds preferentially to K48-chains of polyubiquitinated substrates [7, 17] . It is reasonable that UBL-UBA proteins undergo a conformation change between 'open' and 'closed' forms [16] .
The 'open' form binds to K48-linked ubiquitinated substrates via the C-terminal UBA domain and to the proteasome via the N-terminal UBL domain, which acts as a delivery factor.
Alternatively, the 'closed' form intramolecularly interacts between the UBL K28/K33-linked chains and UBA domains. Ubiquitin chains of the UBL domain may contribute to a conformational change of Dsk2 protein molecules. The difference of chain preference (K48/K28) could endow Dsk2 with a distinct property in the delivery pathway.
Binding of UBL chains to its own UBA domain may affect its own stability. It is possible that the 'stockpile Dsk2' that fails to bind K48 chains of the substrates binds to the UBL K28/K33-chains through its interactions with the UBA domain, resulting in the escape of Dsk2 from degradation. This protection may explain how the wild-type ubiquitinated Dsk2 is able to escape from own degradation by the proteasome. Indeed, wild-type Dsk2 is ubiquitinated, but stable in cells [20] (Figs. 1B, C, and 3B) . In relevant to this, recent works suggest that the UBA domain guard ubiquitin receptors by preventing initiation of degradation at the proteasome [24] .
Our data also show that the Dsk2 UBL domain lacking ubiquitin chains impaired the degradation of Leu--gal (Fig. 4A) and that in vivo Dsk2 function in yeast required the UBL ubiquitination (Fig. 4C) . Moreover, the UBL domain lacking ubiquitin chains decreased the interaction of Dsk2 with polyubiquitinated proteins in cells (Fig. 4B, lane 5 Rad23 and Dsk2 both function in the delivery pathway. In case of Rad23, it has been already shown that the Rad23 stability is mediated by the UBA domain-dependent degradation [15] . Taken together with Dsk2 (this report), we suggest that ubiquitin chains of the UBL domain in UBL-UBA proteins play a distinct role in the ubiquitin-proteasome pathway.
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